IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Savontaus, M.
Right arrow Articles by Sandberg-Lall, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Savontaus, M.
Right arrow Articles by Sandberg-Lall, M.

Investigative Ophthalmology & Visual Science, Vol 38, 930-942, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Localization of type II collagen mRNA isoforms in the developing eyes of normal and transgenic mice with a mutation in type II collagen gene

M Savontaus, T Ihanamaki, M Metsaranta, E Vuorio and M Sandberg-Lall
Department of Medical Biochemistry, University of Turku, Finland.

PURPOSE: To elucidate the function of type II collagen in the development and diseases of the eye by analyzing the temporospatial expression of the long (IIA) and short (IIB) isoforms of type II collagen in the normal and transgenic Dell mice. METHODS: Normal and Dell transgenic embryos harboring a deletion mutation in the pro alpha 1 (II) collagen chain were studied from day 10.5 of embryonic development up to day 10 postpartum. Northern and in situ hybridizations and RNase protection assays were used to study the developmental and temporospatial expression of type II collagen isoforms. RESULTS: Expression of type II collagen mRNAs was observed at all developmental stages with maximum expression at 16.5 days of embryonic development. RNase protection analyses confirmed that both wild type and transgene-derived mRNAs underwent similar alternative splicing of exon 2 in the eye. By in situ hybridization, both isoforms were observed in the cornea, sclera, vitreous, ganglion cell layer of retina, developing ciliary body-iris, and in the retinal pigment epithelium-Bruch's membrane as well as in the lens and conjunctiva. Differences were observed between eyes of Dell mice and of control subjects in the levels and temporal expression patterns of type II collagen mRNA, which resulted in structural abnormalities in histologic analysis. CONCLUSIONS: Widespread expression of type II collagen mRNAs in ocular structures suggests an important role for type II collagen in structural development of the eye. As the expression patterns observed correspond to structural abnormalities in the eyes of Dell mice, the current results offer a promising basis for further development of mouse models for arthroophthalmopathies.


This article has been cited by other articles:


Home page
 IOVSHome page
T. L. Ponsioen, M. J. A. van Luyn, R. J. van der Worp, J. C. van Meurs, J. M. M. Hooymans, and L. I. Los
Collagen Distribution in the Human Vitreoretinal Interface
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4089 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. Takanosu, T. C. Boyd, M. Le Goff, S. P. Henry, Y. Zhang, P. N. Bishop, and R. Mayne
Structure, Chromosomal Location, and Tissue-Specific Expression of the Mouse Opticin Gene
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2202 - 2210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Association for Research in Vision and Ophthalmology